Document ID: chunk:federal_register_of_legislation:C2025C00090:section:99ac
Version: federal_register_of_legislation:C2025C00090
Segment Type: section
Provision Reference: s 99AC
Character Range: 316247–317746

99AC  What this Division is about

      This Division is about price reductions for listed brands of pharmaceutical items.
      Subdivision B requires there to be a price reduction for the first new brand of a pharmaceutical item (other than a combination item) when the brand lists. The listing of the new brand of the pharmaceutical item also provides an automatic trigger for price reductions to occur under Subdivision E (see sections 99ACQ and 99ACR).
      Subdivision C requires there to be a price reduction for the first new brand of a pharmaceutical item that is a combination item when the brand lists. The listing of the new brand of the pharmaceutical item also provides an automatic trigger for price reductions to occur under Subdivision E (see sections 99ACQ and 99ACR).
      Subdivision D provides for other price reductions for pharmaceutical items. These price reductions include reductions that occur on a certain anniversary of the drug in the pharmaceutical item being a listed drug.
      Subdivision E provides for price reductions that are automatically triggered when Subdivision B or C applies to require a first new brand price reduction for a brand of a pharmaceutical item.
      Price reductions for listed brands of pharmaceutical items under this Division are subject to:
         (a) determinations made by the Minister to not apply, or reduce, the price reduction; or
         (b) price reductions made under Subdivision E of Division 3B (see section 99ACG).